BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 26474845)

  • 1. The generation of CD8+ T-cell population specific for vaccinia virus epitope involved in the antiviral protection against ectromelia virus challenge.
    Gierynska M; Szulc-Dabrowska L; Dzieciatkowski T; Golke A; Schollenberger A
    Pathog Dis; 2015 Dec; 73(9):ftv088. PubMed ID: 26474845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection against lethal vaccinia virus challenge in HLA-A2 transgenic mice by immunization with a single CD8+ T-cell peptide epitope of vaccinia and variola viruses.
    Snyder JT; Belyakov IM; Dzutsev A; Lemonnier F; Berzofsky JA
    J Virol; 2004 Jul; 78(13):7052-60. PubMed ID: 15194781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid expansion of CD8+ T cells in wild-type and type I interferon receptor-deficient mice correlates with protection after low-dose emergency immunization with modified vaccinia virus Ankara.
    Volz A; Langenmayer M; Jany S; Kalinke U; Sutter G
    J Virol; 2014 Sep; 88(18):10946-57. PubMed ID: 25008931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active vaccination with vaccinia virus A33 protects mice against lethal vaccinia and ectromelia viruses but not against cowpoxvirus; elucidation of the specific adaptive immune response.
    Paran N; Lustig S; Zvi A; Erez N; Israely T; Melamed S; Politi B; Ben-Nathan D; Schneider P; Lachmi B; Israeli O; Stein D; Levin R; Olshevsky U
    Virol J; 2013 Jul; 10():229. PubMed ID: 23842430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A protein-based smallpox vaccine protects mice from vaccinia and ectromelia virus challenges when given as a prime and single boost.
    Xiao Y; Aldaz-Carroll L; Ortiz AM; Whitbeck JC; Alexander E; Lou H; Davis HL; Braciale TJ; Eisenberg RJ; Cohen GH; Isaacs SN
    Vaccine; 2007 Jan; 25(7):1214-24. PubMed ID: 17098336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection against vaccinia virus challenge by CD8 memory T cells resolved by molecular mimicry.
    Cornberg M; Sheridan BS; Saccoccio FM; Brehm MA; Selin LK
    J Virol; 2007 Jan; 81(2):934-44. PubMed ID: 17079318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of vaccinia CD8+ T-cell epitopes conserved among vaccinia and variola viruses restricted by common MHC class I molecules, HLA-A2 or HLA-B7.
    Terajima M; Cruz J; Leporati AM; Demkowicz WE; Kennedy JS; Ennis FA
    Hum Immunol; 2006 Jul; 67(7):512-20. PubMed ID: 16829305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4+ T cell help is dispensable for protective CD8+ T cell memory against mousepox virus following vaccinia virus immunization.
    Fang M; Remakus S; Roscoe F; Ma X; Sigal LJ
    J Virol; 2015 Jan; 89(1):776-83. PubMed ID: 25355885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid-nanoparticle-encapsulated mRNA vaccines induce protective memory CD8 T cells against a lethal viral infection.
    Knudson CJ; Alves-Peixoto P; Muramatsu H; Stotesbury C; Tang L; Lin PJC; Tam YK; Weissman D; Pardi N; Sigal LJ
    Mol Ther; 2021 Sep; 29(9):2769-2781. PubMed ID: 33992803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterotypic immunity against vaccinia virus in an HLA-B*07:02 transgenic mousepox infection model.
    Kumar A; Suryadevara NC; Wolf KJ; Wilson JT; Di Paolo RJ; Brien JD; Joyce S
    Sci Rep; 2020 Aug; 10(1):13167. PubMed ID: 32759969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization with a single extracellular enveloped virus protein produced in bacteria provides partial protection from a lethal orthopoxvirus infection in a natural host.
    Fang M; Cheng H; Dai Z; Bu Z; Sigal LJ
    Virology; 2006 Feb; 345(1):231-43. PubMed ID: 16256161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obligatory requirement for antibody in recovery from a primary poxvirus infection.
    Chaudhri G; Panchanathan V; Bluethmann H; Karupiah G
    J Virol; 2006 Jul; 80(13):6339-44. PubMed ID: 16775322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective immunity against secondary poxvirus infection is dependent on antibody but not on CD4 or CD8 T-cell function.
    Panchanathan V; Chaudhri G; Karupiah G
    J Virol; 2006 Jul; 80(13):6333-8. PubMed ID: 16775321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Redundant Function of Plasmacytoid and Conventional Dendritic Cells Is Required To Survive a Natural Virus Infection.
    Kaminsky LW; Sei JJ; Parekh NJ; Davies ML; Reider IE; Krouse TE; Norbury CC
    J Virol; 2015 Oct; 89(19):9974-85. PubMed ID: 26202250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epithelial immunization induces polyfunctional CD8+ T cells and optimal mousepox protection.
    Hersperger AR; Siciliano NA; DeHaven BC; Snook AE; Eisenlohr LC
    J Virol; 2014 Aug; 88(16):9472-5. PubMed ID: 24899206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of vaccinia virus epitope-specific HLA-A*0201-restricted T cells and comparative analysis of smallpox vaccines.
    Drexler I; Staib C; Kastenmuller W; Stevanović S; Schmidt B; Lemonnier FA; Rammensee HG; Busch DH; Bernhard H; Erfle V; Sutter G
    Proc Natl Acad Sci U S A; 2003 Jan; 100(1):217-22. PubMed ID: 12518065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitation of CD8+ T cell responses to newly identified HLA-A*0201-restricted T cell epitopes conserved among vaccinia and variola (smallpox) viruses.
    Terajima M; Cruz J; Raines G; Kilpatrick ED; Kennedy JS; Rothman AL; Ennis FA
    J Exp Med; 2003 Apr; 197(7):927-32. PubMed ID: 12668642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Pathogenesis and Immunobiology of Mousepox.
    Sigal LJ
    Adv Immunol; 2016; 129():251-76. PubMed ID: 26791861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maintenance of CD8(+) T-cell memory following infection with recombinant sindbis and vaccinia viruses.
    Villacres MC; Zuo J; Bergmann CC
    Virology; 2000 Apr; 270(1):54-64. PubMed ID: 10772979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies and CD8+ T cells are complementary and essential for natural resistance to a highly lethal cytopathic virus.
    Fang M; Sigal LJ
    J Immunol; 2005 Nov; 175(10):6829-36. PubMed ID: 16272340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.